期刊文献+

A BLIND RANDOMIZED CROSS -OVER TRIAL COMPARING BETAXOLOL WITH TIMOLOL IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION

A BLIND RANDOMIZED CROSS -OVER TRIAL COMPARING BETAXOLOL WITH TIMOLOL IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
暂未订购
导出
摘要 Purpose: To compare the short-term efficacy and side effects of betaxolol and timoloi in treatment of primary open angle glaucoma or ocular hypertension. Methods: Fourteen patients with newly diagnosed early primary open angle glaucoma or ocular hypertension were included.Each patient received 0.5% timoloi and 0.5% betaxolol twice daily for four weeks in two phases. Between two courses of treatment there was four weeks wash out period. At the end of study the effect of these two drugs on intraocular pressure, mean arterial blood pressure,pulse rate,basic tear secretion and ocular symptoms were evaluated and statistically analyzed,using wilcoxon and chi-squar test.RESULTS:The study was performed on fourteen patients with baseline IOP of 26.7 ±1.5 mmHg.After four weeks treatmem,timoiol and betax-olol reduced IOP by 7.8±1.2mmHg or 29% and 6.1±1.3mmHg or 23%, respectively (P<0.001). The difference between two groups was significant(P<0.001). Mean arterial blood pressure was reduced with betaxolol and Purpose: To compare the short-term efficacy and side effects of betaxolol and timoloi in treatment of primary open angle glaucoma or ocular hypertension. Methods: Fourteen patients with newly diagnosed early primary open angle glaucoma or ocular hypertension were included.Each patient received 0.5% timoloi and 0.5% betaxolol twice daily for four weeks in two phases. Between two courses of treatment there was four weeks wash out period. At the end of study the effect of these two drugs on intraocular pressure, mean arterial blood pressure,pulse rate,basic tear secretion and ocular symptoms were evaluated and statistically analyzed,using wilcoxon and chi-squar test.RESULTS:The study was performed on fourteen patients with baseline IOP of 26.7 ±1.5 mmHg.After four weeks treatmem,timoiol and betax-olol reduced IOP by 7.8±1.2mmHg or 29% and 6.1±1.3mmHg or 23%, respectively (P<0.001). The difference between two groups was significant(P<0.001). Mean arterial blood pressure was reduced with betaxolol and timoloi by 4.7±7.1mmHg (P<0. 03), and 3.2±5.6mmHg (P<0.05), respectively, but difference between two groups was not significant (P>0.1). Pulse rate was reduced with timoloi and betaxolol by 8±3.4 beats/min,and 6.5± 5.6 beats/min, respectively(P<0.01), but difference between two groups was not significant (P>0.2). Change in basic tear secretion with timoloi and betxolol was 0.8±2.1 mm/5min (P>0.2), and 0.5±1.9 mm/5min (P>0.3), respectively, and also inter-group comparison was not significant (P>0.5).85.7% of patients using betaxolol and 35.7% using timoloi complained of burning (P<0.01).The other symptoms were similar between two groups.Conclusion: In treatment of early glaucoma or ocular hypertension, it is better to be preferred timoloi over betaxolol, but both drug shoud be used with caution in patients with cardiovascular compromise.
出处 《国际眼科杂志》 CAS 2003年第1期1-1,共1页 International Eye Science
关键词 开角型青光眼 眼内高压 倍他洛尔 噻吗洛尔 疗效 比较研究 盲法随机交叉试验 Btaxolol Timolol Primary open angle glaucoma Oc-ular hypertension
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部